Dr. George Ye is the Chief Scientific Officer and President of Anogen-Yes Biotech Laboratories Ltd since 1989. Dr. Ye is a leading scientist in the field of monoclonal antibody applications and is one of the world's pioneers in anti-chemokine therapy for refractory and complicated diseases.
During the SARS epidemic in 2003, Dr. Ye went to Foshan, Guangdong, China to research the SARS virus. As a result of his research, Dr. Ye discovered and introduced to the world the novel "anti-cytokine storm" bio-defense strategy. In his more than 20 years of research on Alzheimer's disease (AD), Dr. Ye concluded that, given the difficulties of effectively treating patients who have already been affected by AD, a paradigm shift was needed in the fight against AD. To address this need, Dr. Ye introduced to the global community the concept of Pre-AD treatment to prevent the onset of AD. He achieved remarkable results using anti-Abeta42, anti-Tau and other anti-inflammatory antibodies to prevent the onset of AD in mice.
Yes Biotech Laboratories Ltd ISO Certificate, Click on "ISO 13485: 2016 Certificate" below.